• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用患者友好术语列表在药物不良反应报告表中的应用:数据库研究。

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study.

机构信息

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, PO Box 30001, 9700, Groningen, RB, The Netherlands.

MedDRA® Maintenance and Support Services Organization, McLean, VA, USA.

出版信息

Drug Saf. 2019 Jul;42(7):881-886. doi: 10.1007/s40264-019-00800-x.

DOI:10.1007/s40264-019-00800-x
PMID:30725337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6581931/
Abstract

INTRODUCTION

When reporting adverse drug reactions to pharmacovigilance centres, patients and consumers can describe adverse drug reactions experienced in free-text format. Recently, a patient-friendly adverse drug reaction terms list was introduced in the adverse drug reaction report form in the UK to facilitate this reporting.

OBJECTIVE

The objective of this study was to evaluate the actual use of the patient-friendly terms list in the adverse drug reaction report form and its association with the type of adverse drug reactions reported.

METHODS

We conducted a database study in which we reviewed the list's use for all reported adverse drug reactions by patients and consumers to the pharmacovigilance centre in the UK via the online report form between August and September 2017. Descriptive statistics were used. In addition, for adverse drug reactions reported more than 20 times, Chi-squared tests were used to test for differences in the number of reports in which the patient-friendly terms list was used and those in which the adverse drug reaction was entered as free text.

RESULTS

In total, 888 reports were received. In 185 reports (21%), the patient-friendly terms list was used to enter an adverse drug reaction. In total, the reports contained 3227 adverse drug reactions. Nausea, headache, diarrhoea, dizziness, insomnia, anxiety, depression, fatigue, tiredness, vomiting, appetite lost, joint pain, chest pain, constipation and pain were reported more than 20 times. Five of these adverse drug reactions (i.e. nausea, diarrhoea, dizziness, insomnia and constipation) were reported significantly more often in reports where the adverse drug reactions were selected from the patient-friendly terms list.

CONCLUSIONS

Most people chose to describe adverse drug reactions in their own words rather than selecting adverse drug reactions from a patient-friendly terms list. Although the patient-friendly terms list may be a useful feature for some patients or for some adverse drug reactions, it should not replace the option for patients to describe adverse drug reactions in their own words.

摘要

简介

当向药物警戒中心报告药物不良反应时,患者和消费者可以用自由文本格式描述所经历的药物不良反应。最近,英国在药物不良反应报告表中引入了便于报告的患者友好型药物不良反应术语列表。

目的

本研究旨在评估该患者友好型术语列表在药物不良反应报告表中的实际使用情况及其与报告的药物不良反应类型的关系。

方法

我们开展了一项数据库研究,其中我们回顾了 2017 年 8 月至 9 月期间通过英国在线报告表向药物警戒中心报告的患者和消费者报告的所有药物不良反应中该列表的使用情况。使用描述性统计。此外,对于报告超过 20 次的药物不良反应,使用卡方检验检验使用患者友好型术语列表和以自由文本形式输入药物不良反应的报告数量差异。

结果

共收到 888 份报告。在 185 份报告(21%)中,使用患者友好型术语列表输入药物不良反应。报告共包含 3227 种药物不良反应。恶心、头痛、腹泻、头晕、失眠、焦虑、抑郁、疲劳、乏力、呕吐、食欲丧失、关节痛、胸痛、便秘和疼痛报告超过 20 次。其中五种药物不良反应(即恶心、腹泻、头晕、失眠和便秘)在从患者友好型术语列表中选择药物不良反应的报告中报告的频率明显更高。

结论

大多数人选择用自己的话描述药物不良反应,而不是从患者友好型术语列表中选择药物不良反应。尽管患者友好型术语列表对于某些患者或某些药物不良反应可能是有用的功能,但它不应替代患者用自己的话描述药物不良反应的选项。

相似文献

1
Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study.使用患者友好术语列表在药物不良反应报告表中的应用:数据库研究。
Drug Saf. 2019 Jul;42(7):881-886. doi: 10.1007/s40264-019-00800-x.
2
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
3
Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers - Retrospective Data-base Study.保加利亚患者和消费者药品不良反应报告的经验——回顾性数据库研究
Folia Med (Plovdiv). 2018 Sep 1;60(3):447-453. doi: 10.2478/folmed-2018-0016.
4
Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.尼日利亚门诊患者对不良反应的知识、意识、看法和报告。
Int J Clin Pharm. 2019 Aug;41(4):1062-1073. doi: 10.1007/s11096-019-00849-9. Epub 2019 May 28.
5
Patient Reporting in the EU: Analysis of EudraVigilance Data.欧盟的患者报告:EudraVigilance数据的分析。
Drug Saf. 2017 Jul;40(7):629-645. doi: 10.1007/s40264-017-0534-1.
6
Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.评估自然语言处理 (NLP) 系统,以使用 MedDRA 术语对药品标签进行注释。
J Biomed Inform. 2018 Jul;83:73-86. doi: 10.1016/j.jbi.2018.05.019. Epub 2018 Jun 1.
7
Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP: A Comparison with Classical Methods of Reporting.通过移动应用程序 VigiBIP 收到的药物不良反应报告:与传统报告方法的比较。
Drug Saf. 2018 May;41(5):511-514. doi: 10.1007/s40264-017-0630-2.
8
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.欧洲和意大利的药物警戒工作流程及药物警戒术语。
Int J Clin Pharm. 2018 Aug;40(4):748-753. doi: 10.1007/s11096-018-0711-z. Epub 2018 Aug 9.
9
Adverse drug reactions in neonates: could we be documenting more?新生儿的药物不良反应:我们是否能记录得更多?
Expert Rev Clin Pharmacol. 2014 Nov;7(6):807-20. doi: 10.1586/17512433.2014.956090. Epub 2014 Sep 16.
10
MedDRA and pharmacovigilance: a complex and little-evaluated tool.医学术语词典(MedDRA)与药物警戒:一种复杂且鲜少被评估的工具。
Prescrire Int. 2016 Oct;25(175):247-250.

引用本文的文献

1
Development of a Patient-Centered Symptom-Reporting Application in Pharmacy Settings Using a Hierarchical Patient-Friendly Symptom List: Developmental and Usability Study.使用分层患者友好症状列表在药房环境中开发以患者为中心的症状报告应用程序:开发与可用性研究
JMIR Hum Factors. 2025 Mar 6;12:e71439. doi: 10.2196/71439.
2
Physicians' Perspectives on HL7 Information Policy Sensitive Value Set: A Validation Study through Health Concept Categorization.医生对HL7信息政策敏感值集的看法:通过健康概念分类进行的验证研究。
Healthcare (Basel). 2023 Oct 28;11(21):2845. doi: 10.3390/healthcare11212845.
3
Mobile apps for quick adverse drug reaction report: A scoping review.移动应用程序快速不良反应报告:范围综述。
Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):19-27. doi: 10.1002/pds.5542. Epub 2022 Sep 30.
4
Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.移动应用程序在药品安全信息收集和交流方面的使用建议:来自 IMI WEB-RADR 的经验教训。
Drug Saf. 2019 Apr;42(4):477-489. doi: 10.1007/s40264-019-00813-6.

本文引用的文献

1
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.使用 VigiBase 在协作信号检测研讨会上报告的患者报告的安全问题:Lareb 和 Uppsala 监测中心的结果和反思。
Drug Saf. 2018 Feb;41(2):203-212. doi: 10.1007/s40264-017-0594-2.
2
Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.影响使用移动应用报告药物不良反应及接收安全信息的因素:一项定性研究
Drug Saf. 2017 May;40(5):443-455. doi: 10.1007/s40264-016-0494-x.
3
Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.患者对药物不良反应的报告:各国主管当局观点与需求的国际调查
Drug Saf. 2016 Nov;39(11):1105-1116. doi: 10.1007/s40264-016-0453-6.
4
The value of patient reporting to the pharmacovigilance system: a systematic review.患者向药物警戒系统报告的价值:一项系统评价
Br J Clin Pharmacol. 2017 Feb;83(2):227-246. doi: 10.1111/bcp.13098. Epub 2016 Oct 12.
5
Adverse drug event reporting systems: a systematic review.药品不良事件报告系统:一项系统综述
Br J Clin Pharmacol. 2016 Jul;82(1):17-29. doi: 10.1111/bcp.12944. Epub 2016 May 9.
6
Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists.不同年龄组的药物不良反应模式:社区药剂师自发报告分析
PLoS One. 2015 Jul 14;10(7):e0132916. doi: 10.1371/journal.pone.0132916. eCollection 2015.
7
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.患者报告的安全事件报告中的结局指标:PROSPER 联盟指南。
Drug Saf. 2013 Dec;36(12):1129-49. doi: 10.1007/s40264-013-0113-z.
8
Experiences with adverse drug reaction reporting by patients: an 11-country survey.患者药物不良反应报告经验:11 国调查。
Drug Saf. 2012 Jan 1;35(1):45-60. doi: 10.2165/11594320-000000000-00000.
9
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
10
Quality check of spontaneous adverse drug reaction reporting forms of different countries.不同国家自发药物不良反应报告表的质量检查。
Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1181-5. doi: 10.1002/pds.2004.